Gliknik's Series B Round

Gliknik raised a round of funding on October 08, 2012.

Gliknik is a privately held biopharmaceutical company creating new therapies for patients with cancer and immune disorders. Gliknik specializes in the modulation of the immune system to fight disease.…

Articles about Gliknik's Series B Round: